Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
9.65
+0.28 (2.99%)
At close: Sep 18, 2026, 4:00 PM EDT
9.65
0.00 (0.00%)
Pre-market: Sep 21, 2026, 4:02 AM EDT
Evommune Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Evommune stock has a consensus rating of "Buy" and an average price target of $24.13. The average 1-year stock price forecast is 150.05% higher than the current stock price, while the lowest is $18 (+86.53%) and the highest is $30 (+210.88%).
Price Target: $24.13 (+150.05%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Evommune stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 3 | 3 | 4 | 3 |
| Hold | 0 | 0 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 18, 2026 |
| Clear Street | Clear Street | Buy Maintains $28 → $23 | Buy | Maintains | $28 → $23 | +138.34% | Sep 9, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $30 | Buy | Maintains | $30 | +210.88% | Sep 9, 2026 |
| Needham | Needham | Buy Maintains $28 | Buy | Maintains | $28 | +190.16% | Sep 9, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $28 → $22 | Buy | Reiterates | $28 → $22 | +127.98% | Sep 9, 2026 |
Financial Forecast
Revenue This Year
625.00K
from 13.00M
Decreased by -95.19%
Revenue Next Year
875.00K
from 625.00K
Increased by 40.00%
EPS This Year
-3.46
from -11.22
EPS Next Year
-3.44
from -3.46
EPS and Forward PE are based on non-GAAP adjusted numbers.